GILD logo

Gilead Sciences (GILD)

Profile

Full Name

Gilead Sciences, Inc.

Ticker Symbol

GILD

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

January 22, 1992

Indexes

S&P 500,NASDAQ 100

Website

http://www.gilead.com

Employees

17600

Key Details

Price

$104.54(-0.32%)

Market cap

$130.19B(Mega cap)

Last Dividend

$0.79

TTM Dividend yield

2.97%

Annual revenue

$28.75B(+6.04% YoY)

Annual EPS

$0.38(-91.56% YoY)

PE ratio

282.54

Next earnings date

Apr 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$104.54
GILD price is $104.54

30-Day Relative Volume

0.78
GILD 30-day relative volume is 0.78

Price Performance

Price Today change

-0.32%
GILD price is down -0.32% today

Price YTD change

+13.18%
GILD price is up +13.18% since January 1st

Price 1-year change

+56.19%
GILD price is up +56.19% year-on-year

Price 3-year change

+69.1%
GILD price is up +69.1% over the past 3 years

Price Range

Price All-time high

$123.37
GILD price is currently -15.26% below its historical high of $123.37

Price 3-year low

$57.17
GILD price is currently +82.86% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$130.19B
GILD market capitalization is $130.19 billion

Market cap 3-year change

+67.8%
GILD market capitalization is up +67.8% over the past 3 years

Market cap All-time high

$179.60B
GILD market capitalization is currently -27.51% below its historical high of $179.60 billion

Market cap sector rank

98.77%
GILD market capitalization is higher than 98.77% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.13%
GILD shares outstanding is down -0.13% year-on-year

Shares Outstanding 3-Year Change

-0.77%
GILD shares outstanding is down -0.77% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.24
GILD beta is 0.24

200-day SMA

$90.76
GILD price is currently +15.18% above its 200-day simple moving average

50-day SMA

$108.53
GILD price is currently -3.68% below its 50-day simple moving average

RSI

43.48
GILD 14-day relative strength index is 43.48

Volume

0.78
GILD 30-day relative volume is 0.78

ATR

$3.66
GILD average true range is $3.66

10-day Historical Volatility

39.15%
GILD 10-day historical volatility is 39.15%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.79
GILD last dividend was $0.79 per share, with an ex-dividend date of March 14, 2025

Next Dividend

-
GILD next dividend has not yet been announced

Dividend per share

Dividend per share

$3.08
GILD annual dividend per share is $3.08

Dividend per share Sector Rank

84.88%
GILD annual dividend per share is higher than 84.88% of companies in Healthcare sector

Dividend per share 1-Year Change

+2.67%
GILD annual dividend per share is up +2.67% year-on-year

Dividend per share 3-Year Change

+8.45%
GILD annual dividend per share is up +8.45% over the past 3 years

Dividend yield

Dividend yield

2.95%
GILD annual dividend yield is 2.95%

Dividend yield Sector Rank

61.18%
GILD annual dividend yield is higher than 61.18% of companies in Healthcare sector

Other

Payout ratio

816.25%
GILD annual payout ratio is 816.25%

Dividends paid

$3.92B
GILD annual dividends paid is $3.92 billion

Free cash flow

$10.83B
GILD annual free cash flow is $10.83 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$28.75B
GILD annual revenue is $28.75 billion

Revenue Analysts estimate

$28.70B
GILD annual revenue is currently +0.20% higher than the consensus analysts' forecast

Revenue 1-year change

+6.04%
GILD annual revenue is up +6.04% year-on-year

Revenue Sector rank

96.86%
GILD annual revenue is higher than 96.86% of companies in Healthcare sector

EPS

EPS

$0.38
GILD annual earnings per share is $0.38

EPS Analysts estimate

$7.93
GILD annual earnings per share is currently -95.21% lower than the consensus analysts' forecast

EPS 1-year change

-91.56%
GILD annual earnings per share is down -91.56% year-on-year

EPS Sector rank

86.36%
GILD annual earnings per share is higher than 86.36% of companies in Healthcare sector

Profit

Gross profit

$22.50B
GILD annual gross profit is $22.50 billion

Gross margin

78.26%
GILD annual gross profit margin is 78.26%

Operating profit

$10.51B
GILD annual operating income is $10.51 billion

Operating margin

36.53%
GILD annual operating profit margin is 36.53%

Net income

$480.00M
GILD annual net profit is $480.00 million

Net margin

1.67%
GILD annual net profit margin is 1.67%

Expenses

Total expenses

$18.25B
GILD annual total expenses is $18.25 billion

Operating expenses

$12.00B
GILD annual total operating expenses is $12.00 billion

Cost of goods sold

$6.25B
GILD annual cost of goods sold is $6.25 billion

Selling, general & administrative expenses

$6.09B
GILD annual SGA is $6.09 billion

Depreciation and amortization

$2.77B
GILD annual depreciation & amortization is $2.77 billion

Interest expense

$977.00M
GILD annual interest expense is $977.00 million

Income tax

$211.00M
GILD annual income tax is $211.00 million

EBIT & EBITDA

EBIT

$1.67B
GILD annual earnings before interest & taxes is $1.67 billion

EBITDA

$1.67B
GILD annual EBITDA is $1.67 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$58.99B
GILD annual total assets is $58.99 billion

Non current assets

$40.99B
GILD annual long term assets is $40.99 billion

Current assets

$18.00B
GILD annual total current assets is $18.00 billion

Cash and cash equivalents

$9.99B
GILD annual cash & cash equivalents is $9.99 billion

Accounts receivable

$4.42B
GILD annual accounts receivable is $4.42 billion

Inventory

$1.71B
GILD annual inventory is $1.71 billion

Liabilities

Total liabilities

$39.75B
GILD annual total liabilities is $39.75 billion

Long term liabilities

$27.75B
GILD annual total long term liabilities is $27.75 billion

Current liabilities

$12.00B
GILD annual total current liabilities is $12.00 billion

Accounts payable

$833.00M
GILD annual accounts payable is $833.00 million

Debt

Total debt

$26.71B
GILD annual total debt is $26.71 billion

Total debt 1-year change

+6.9%
GILD annual total debt is up +6.9% year-on-year

Long term debt

$24.90B
GILD annual long term debt is $24.90 billion

Short term debt

$1.81B
GILD annual short term debt is $1.81 billion

Equity & Capital

Shareholders equity

$19.33B
GILD annual stockholders equity is $19.33 billion

Book value

$19.25B
GILD annual book value is $19.25 billion

Retained earnings

$11.50B
GILD annual retained earnings is $11.50 billion

Working capital

$6.00B
GILD annual working capital is $6.00 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$10.83B
GILD annual cash flow from operations is $10.83 billion

Cash from operations 1-year change

+35.25%
GILD annual cash flow from operations is up +35.25% year-on-year

Cash from investing

-$3.45B
GILD annual cash flow from investing activities is -$3.45 billion

Cash from investing 1-year change

-52.27%
GILD annual cash flow from investing activities is down -52.27% year-on-year

Cash from financing

-$3.43B
GILD annual cash flow from financing activities is -$3.43 billion

Cash from financing 1-year change

+33.01%
GILD annual cash flow from financing activities is up +33.01% year-on-year

CAPEX

CAPEX

$523.00M
GILD annual capital expenditures is $523.00 million

CAPEX 1-year change

-10.6%
GILD annual capital expenditures is down -10.6% year-on-year

Free Cash Flow

Free cash flow

$10.83B
GILD annual free cash flow is $10.83 billion

Free cash flow 1-year change

+45.91%
GILD annual free cash flow is up +45.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

78.26%
GILD annual gross profit margin is 78.26%

Operating margin

36.53%
GILD annual operating profit margin is 36.53%

Net margin

1.67%
GILD annual net profit margin is 1.67%

ROA & ROE

ROA

0.79%
GILD annual return on assets is 0.79%

ROE

2.29%
GILD annual return on equity is 2.29%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

282.54
GILD price to earnings ratio is 282.54

PE ratio Sector rank

96.57%
GILD price to earnings ratio is higher than 96.57% of companies in Healthcare sector

PB Ratio

PB ratio

6.74
GILD price to book ratio is 6.74

PB ratio Sector rank

88.3%
GILD price to book ratio is higher than 88.3% of companies in Healthcare sector

PS Ratio

PS ratio

4.53
GILD price to sales ratio is 4.53

PS ratio Sector rank

64.36%
GILD price to sales ratio is higher than 64.36% of companies in Healthcare sector

Enterprise value

Enterprise value

$146.91B
GILD enterprise value is $146.91 billion

Enterprise value Sector rank

98.84%
GILD enterprise value is higher than 98.84% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

39.26
GILD EV/EBITDA is 39.26

EV/EBITDA Sector rank

95.83%
GILD EV/EBITDA is higher than 95.83% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.50
GILD annual current ratio is 1.50

Quick ratio

1.36
GILD annual quick ratio is 1.36

Leverage

Debt to equity

0.00
GILD annual debt to equity ratio is 0.00

Interest coverage ratio

1.71
GILD annual interest coverage ratio is 1.71

Risk & Stability

Piotroski F-Score

7
GILD piotroski f-score is 7

Altman Z-Score

2.94
GILD altman z-score is 2.94

Analyst ratings

Recent major analysts updates

Mar 27, 25 JP Morgan
Overweight
Mar 11, 25 Morgan Stanley
Overweight
Mar 5, 25 Wells Fargo
Overweight
Mar 5, 25 B of A Securities
Buy
Mar 4, 25 Oppenheimer
Outperform
Feb 18, 25 Deutsche Bank
Buy
Feb 12, 25 Wells Fargo
Overweight
Feb 12, 25 RBC Capital
Sector Perform
Feb 12, 25 Piper Sandler
Overweight
Feb 12, 25 Needham
Hold

Institutional Ownership

Similar stocks

SYK logo
Stryker (SYK)
SNY logo
Sanofi (SNY)
DHR logo
Danaher (DHR)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
PFE logo
Pfizer (PFE)
BSX logo
Boston Scientific (BSX)
AMGN logo
Amgen (AMGN)
MDT logo
Medtronic (MDT)
BMY logo
Bristol-Myers Squibb (BMY)
  • What is the ticker symbol for Gilead Sciences?
  • Does Gilead Sciences pay dividends?
  • What sector is Gilead Sciences in?
  • What industry is Gilead Sciences in?
  • What country is Gilead Sciences based in?
  • When did Gilead Sciences go public?
  • Is Gilead Sciences in the S&P 500?
  • Is Gilead Sciences in the NASDAQ 100?
  • Is Gilead Sciences in the Dow Jones?
  • When was Gilead Sciences's last earnings report?
  • When does Gilead Sciences report earnings?
  • Should I buy Gilead Sciences stock now?

What is the ticker symbol for Gilead Sciences?

The ticker symbol for Gilead Sciences is NASDAQ:GILD

Does Gilead Sciences pay dividends?

Yes, Gilead Sciences pays dividends. The last payment was $0.79, with an ex-dividend date on March 14, 2025

What sector is Gilead Sciences in?

Gilead Sciences is in the Healthcare sector

What industry is Gilead Sciences in?

Gilead Sciences is in the Drug Manufacturers - General industry

What country is Gilead Sciences based in?

Gilead Sciences is headquartered in United States

When did Gilead Sciences go public?

Gilead Sciences's initial public offering (IPO) was on January 22, 1992

Is Gilead Sciences in the S&P 500?

Yes, Gilead Sciences is included in the S&P 500 index

Is Gilead Sciences in the NASDAQ 100?

Yes, Gilead Sciences is included in the NASDAQ 100 index

Is Gilead Sciences in the Dow Jones?

No, Gilead Sciences is not included in the Dow Jones index

When was Gilead Sciences's last earnings report?

Gilead Sciences's most recent earnings report was on Feb 11, 2025

When does Gilead Sciences report earnings?

The next expected earnings date for Gilead Sciences is Apr 24, 2025

Should I buy Gilead Sciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page